Cell-mediated immunity is an immune response that does not involve antibodies but rather involves the activation of phagocytes, natural killer cells (NK), antigen-specific cytotoxic T-lymphocytes, and the release of various cytokines in response to an antigen. Historically, the immune system was separated into two branches: humoral immunity, for which the protective function of immunization could be found in the humor (cell-free bodily fluid or serum) and cellular immunity, for which the protective function of immunization was associated with cells. CD4 cells or helper T cells provide protection against different pathogens. Cytotoxic T cells cause death by apoptosis without using cytokines, therefore in cell mediated immunity cytokines are not always present.
Cellular immunity protects the body by:
- activating antigen-specific cytotoxic T-lymphocytes that are able to induce apoptosis in body cells displaying epitopes of foreign antigen on their surface, such as virus-infected cells, cells with intracellular bacteria, and cancer cells displaying tumor antigens;
- activating macrophages and natural killer cells, enabling them to destroy pathogens; and
- stimulating cells to secrete a variety of cytokines that influence the function of other cells involved in adaptive immune responses and innate immune responses.
Cell-mediated immunity is directed primarily at microbes that survive in phagocytes and microbes that infect non-phagocytic cells. It is most effective in removing virus-infected cells, but also participates in defending against fungi, protozoans, cancers, and intracellular bacteria. It also plays a major role in transplant rejection.
Myeloid lineage - Blood (WBC and RBC)
|
|
Cellular/
HSCs |
Myeloid/
CFU-GEMM
|
CFU-GM
|
CFU-G:
Granulocytes
|
Band cell · Neutrophil
|
|
CFU-M:
Monocytes/
MPS
|
Macrophages
|
Histiocytes · Kupffer cells · Alveolar macrophage · Microglia · Osteoclasts · Epithelioid cells · giant cells (Langhans giant cells, Foreign-body giant cell, Touton giant cells)
|
|
CFU-DL
|
Dendritic cells · Langerhans cell
|
|
|
Common
|
Myelomonocyte
|
|
|
CFU-Baso
|
Granulocytes (Basophil)
|
|
CFU-Eos
|
Granulocytes (Eosinophil)
|
|
MEP
|
CFU-Meg
|
Megakaryoblast (* primitive Kacheshmarova's cell) · Megakaryocyte (Kacheshmarova's cell) · Platelets
|
|
CFU-E
|
Reticulocyte · Normoblast
|
|
|
CFU-Mast
|
Mast cell precursors
|
|
|
|
Noncellular |
Plasma
|
|
M: MYL
|
cell/phys (coag, heme, immu, gran), csfs
|
rbmg/mogr/tumr/hist, sysi/epon, btst
|
drug (B1/2/3+5+6), btst, trns
|
|
|
|
Immunology: Lymphocytic adaptive immune system and complement
|
|
Lymphoid |
Antigens
|
- Antigen presentation/Professional APCs: Dendritic cell
- Macrophage
- B cell
|
|
Antibodies
|
- Antibody
- Monoclonal antibodies
- Polyclonal antibodies
- Autoantibody
- Microantibody
- Polyclonal B cell response
- Allotype
- Isotype
- Idiotype
|
|
Immunity vs.
tolerance
|
- action: Immunity
- Autoimmunity
- Alloimmunity
- Allergy
- Hypersensitivity
- Inflammation
- Cross-reactivity
- inaction: Tolerance
- Central
- Peripheral
- Clonal anergy
- Clonal deletion
- Tolerance in pregnancy
- Immunodeficiency
|
|
Immunogenetics
|
- Affinity maturation (Somatic hypermutation
- Clonal selection)
- V(D)J recombination
- Junctional diversity
- Immunoglobulin class switching
- MHC/HLA
|
|
|
Lymphocytes |
- Cellular (T cell)
- Humoral (B cell)
- NK cell
|
|
Substances |
- Cytokines
- Opsonin
- Cytolysin
|
|
Complement |
|
|
M: LMC
|
cell/phys/auag/auab/comp, igrc
|
imdf/ipig/hyps/tumr
|
proc, drug(L3/4)
|
|
|
|
Immune disorders: hypersensitivity and autoimmune diseases (279.5–6)
|
|
Type I/allergy/atopy
(IgE) |
Foreign
|
Atopic dermatitis · Allergic urticaria · Hay fever · Allergic asthma · Anaphylaxis · Food allergy (Milk, Egg, Peanut, Tree nut, Seafood, Soy, Wheat), Penicillin allergy
|
|
Autoimmune
|
none
|
|
|
Type II/ADCC
(IgM, IgG) |
Foreign
|
Pernicious anemia · Hemolytic disease of the newborn
|
|
Autoimmune
|
Cytotoxic
|
Autoimmune hemolytic anemia · Idiopathic thrombocytopenic purpura · Bullous pemphigoid · Pemphigus vulgaris · Rheumatic fever · Goodpasture's syndrome
|
|
"Type 5"/receptor
|
Graves' disease · Myasthenia gravis
|
|
|
|
Type III
(Immune complex) |
Foreign
|
Henoch–Schönlein purpura · Hypersensitivity vasculitis · Reactive arthritis · Farmer's lung · Post-streptococcal glomerulonephritis · Serum sickness · Arthus reaction
|
|
Autoimmune
|
Systemic lupus erythematosus · Subacute bacterial endocarditis · Rheumatoid arthritis
|
|
|
Type IV/cell-mediated
(T-cells) |
Foreign
|
Allergic contact dermatitis · Mantoux test
|
|
Autoimmune
|
Diabetes mellitus type 1 · Hashimoto's thyroiditis · Guillain–Barré syndrome · Multiple sclerosis · Coeliac disease · Giant-cell arteritis
|
|
GVHD
|
Transfusion-associated graft versus host disease
|
|
|
Unknown/
multiple |
Foreign
|
Hypersensitivity pneumonitis (Allergic bronchopulmonary aspergillosis) · Transplant rejection · Latex allergy (I+IV)
|
|
Autoimmune
|
Sjögren's syndrome · Autoimmune hepatitis · Autoimmune polyendocrine syndrome (APS1, APS2) · Autoimmune adrenalitis · Systemic autoimmune disease
|
|
|
M: LMC
|
cell/phys/auag/auab/comp, igrc
|
imdf/ipig/hyps/tumr
|
proc, drug(L3/4)
|
|
|
|